FERMENTA BIOTECH LIMITED (FERMENTA.BO)

INR 393.0

(-0.57%)

Total Liabilities Summary of FERMENTA BIOTECH LIMITED

FERMENTA BIOTECH LIMITED's latest annual total liabilities in 2023 was 2.62 Billion INR , down -27.45% from previous year.
FERMENTA BIOTECH LIMITED's latest quarterly total liabilities in 2024 Q1 was -2.85 Billion INR , down -208.56% from previous quarter.
FERMENTA BIOTECH LIMITED reported annual total liabilities of 3.62 Billion INR in 2022, up 0.66% from previous year.
FERMENTA BIOTECH LIMITED reported annual total liabilities of 3.59 Billion INR in 2021, up 3.59% from previous year.
FERMENTA BIOTECH LIMITED reported quarterly total liabilities of 3.06 Billion INR for 2023 FY, down -15.23% from previous quarter.
FERMENTA BIOTECH LIMITED reported quarterly total liabilities of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Liabilities Chart of FERMENTA BIOTECH LIMITED (2023 - 2012)

Historical Annual Total Liabilities of FERMENTA BIOTECH LIMITED (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	2.62 Billion INR	-27.45%
2022	3.62 Billion INR	0.66%
2021	3.59 Billion INR	3.59%
2020	3.47 Billion INR	8.65%
2019	3.19 Billion INR	1.37%
2018	3.15 Billion INR	21.4%
2017	2.59 Billion INR	87.16%
2016	1.38 Billion INR	2.96%
2015	1.34 Billion INR	24.61%
2014	1.08 Billion INR	4.35%
2013	1.03 Billion INR	32.58%
2012	781.7 Million INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	-2.85 Billion INR	-208.56%
2023 FY	3.06 Billion INR	-15.23%
2023 Q1	- INR	-100.0%
2023 Q2	3.11 Billion INR	0.0%
2023 Q4	2.62 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2022 Q1	- INR	-100.0%
2022 Q2	3.5 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	3.59 Billion INR	0.0%
2022 FY	3.62 Billion INR	0.66%
2021 FY	3.59 Billion INR	3.59%
2021 Q4	3.59 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q2	3.17 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2020 Q4	3.47 Billion INR	0.0%
2020 FY	3.47 Billion INR	8.65%
2020 Q1	- INR	-100.0%
2020 Q2	3.4 Billion INR	0.0%
2020 Q3	- INR	-100.0%
2019 Q3	- INR	-100.0%
2019 Q1	- INR	-100.0%
2019 FY	3.19 Billion INR	1.37%
2019 Q2	3.32 Billion INR	0.0%
2019 Q4	3.04 Billion INR	0.0%
2018 Q4	3 Billion INR	0.0%
2018 FY	3.15 Billion INR	21.4%
2018 Q3	- INR	-100.0%
2018 Q2	3.2 Billion INR	0.0%
2018 Q1	- INR	-100.0%
2017 Q2	1.5 Billion INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	2.49 Billion INR	0.0%
2017 FY	2.59 Billion INR	87.16%
2017 Q1	- INR	-100.0%
2016 FY	1.38 Billion INR	2.96%
2016 Q4	1.34 Billion INR	0.0%
2016 Q3	- INR	-100.0%
2016 Q2	1.28 Billion INR	0.0%
2015 Q2	1.25 Billion INR	0.0%
2015 Q1	- INR	-100.0%
2015 FY	1.34 Billion INR	24.61%
2015 Q4	1.32 Billion INR	0.0%
2015 Q3	- INR	-100.0%
2014 Q2	918.56 Million INR	0.0%
2014 Q3	- INR	-100.0%
2014 Q1	- INR	-100.0%
2014 FY	1.08 Billion INR	4.35%
2014 Q4	1.08 Billion INR	0.0%
2013 FY	1.03 Billion INR	32.58%
2013 Q3	- INR	-100.0%
2013 Q4	1.03 Billion INR	0.0%
2013 Q2	729.59 Million INR	0.0%
2012 Q3	- INR	0.0%
2012 FY	781.7 Million INR	0.0%
2012 Q4	781.7 Million INR	0.0%

Peer Total Liabilities Comparison of FERMENTA BIOTECH LIMITED

Name	Total Liabilities	Total Liabilities Difference
Alfavision Overseas (India) Limited	1.36 Billion INR	-92.303%
Biocon Limited	307.95 Billion INR	99.147%
Blue Jet Healthcare Limited	2.13 Billion INR	-22.959%
Concord Biotech Limited	1.74 Billion INR	-50.904%
Dishman Carbogen Amcis Limited	39.53 Billion INR	93.357%
GENOMIC VALLEY BIOTECH LIMITED	7.91 Million INR	-33081.357%
Lyka Labs Limited	884.58 Million INR	-196.938%
Panacea Biotec Limited	4.02 Billion INR	34.663%
SAMSRITA LABS LIMITED	32.93 Million INR	-7875.336%
Servoteach Industries Limited	5275.00 INR	-49794724.664%
SMS Lifesciences India Limited	1.96 Billion INR	-33.413%
Supriya Lifescience Limited	1.05 Billion INR	-148.104%
Syngene International Limited	18.93 Billion INR	86.131%
TAKE Solutions Limited	969.78 Million INR	-170.853%
Titan Biotech Limited	231.28 Million INR	-1035.679%
Transgene Biotek Limited	393.11 Million INR	-568.177%
Vanta Bioscience Limited	724.23 Million INR	-262.683%